Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
4(27%)
Results Posted
71%(5 trials)
Terminated
2(13%)

Phase Distribution

Ph not_applicable
5
33%
Ph phase_2
3
20%
Ph phase_1
1
7%
Ph phase_4
1
7%
Ph phase_3
4
27%

Phase Distribution

1

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
1(7.1%)
Phase 2Efficacy & side effects
3(21.4%)
Phase 3Large-scale testing
4(28.6%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
5(35.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

4

trials recruiting

Total Trials

15

all time

Status Distribution
Active(5)
Completed(7)
Terminated(3)

Detailed Status

Completed7
Recruiting4
Terminated2
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
4
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.1%)
Phase 23 (21.4%)
Phase 34 (28.6%)
Phase 41 (7.1%)
N/A5 (35.7%)

Trials by Status

recruiting427%
withdrawn17%
terminated213%
completed747%
not_yet_recruiting17%

Recent Activity

4 active trials
Showing 5 of 15
recruitingnot_applicable

EMG-guided Botox Injection Versus Conventional Botox Injection in Gummy Smile Patients

NCT06075134
terminatedphase_3

Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral Palsy

NCT03616067
terminatednot_applicable

Evaluation of Three Types of Injection for the Treatment of Lateral Epicondylalgia

NCT02325063
completedphase_3

Sling vs Botox for Mixed Incontinence

NCT04171531
not_yet_recruitingphase_3

Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease

NCT05698979
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT06075134Not Applicable

EMG-guided Botox Injection Versus Conventional Botox Injection in Gummy Smile Patients

Recruiting
NCT03616067Phase 3

Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral Palsy

Terminated
NCT02325063Not Applicable

Evaluation of Three Types of Injection for the Treatment of Lateral Epicondylalgia

Terminated
NCT04171531Phase 3

Sling vs Botox for Mixed Incontinence

Completed
NCT05698979Phase 3

Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease

Not Yet Recruiting
NCT06543979Phase 1

Anorectal Manometery in Pediatric Chronic Refractory Constipation

Recruiting
NCT06553950Not Applicable

Mandibular Splint vs Botox Injection in Lateral Pterygoid on Cervical Muscle Activity in Patients With Temporomandibular Disorders

Recruiting
NCT05191719Not Applicable

Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy

Recruiting
NCT02177617Phase 4

Neurotoxin and Physical Therapy

Completed
NCT02510040

A Prospective Observational Study of Adult Strabismus

Completed
NCT05620316Not Applicable

The Use of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle to Treat Sleep Bruxism

Completed
NCT02058836Phase 2

Botulinum Toxin for the Management of Chronic Orchialgia

Completed
NCT01502956Phase 3

Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)

Completed
NCT01551940Phase 2

Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea

Completed
NCT00681148Phase 2

Botulinum Toxin Injection With Prostate Brachytherapy

Withdrawn

All 15 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
15